Know a great AI tool or AI news source? Submit it to AiByts
CataX1 min read

CataX AI raises RMB 40 million to bring AI agents into clinical drug development

Shanghai-based CataX AI has raised RMB 40 million in a seed round from Qiming Venture Partners, which incubated the startup and was the sole investor. CataX AI plans to license or co-develop drug candidates at the preclinical or early clinical stage and advance them through clinical proof of…

By TechNode FeedTechNode - China AI
CataX AI raises RMB 40 million to bring AI agents into clinical drug development

Read the full story

Originally published by TechNode - China AI on Nov 16, 2026.

Read on TechNode - China AI(opens in a new tab)

Comments

Sign in to join the discussion.

No comments yet — be the first to share your thoughts.